References
- Levy G., Houston J. B. Effect of activated charcoal on acetaminophen absorption. Pediatrics 1976; 58: 432–435
- Slattery J. T., Levy G. Acetaminophen kinetics in acutely poisoned patients. Clin. Pharmacol. Ther. 1979; 25: 185–195
- Lin J. H., Levy G. Sulfate depletion after acetaminophen administration and replenishment by infusion of sodium sulfate or N-acetylcysteine in rats. Biochem. Pharmacol. 1981; 30: 2723–2725
- Galinsky R. E., Levy G. Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion. J. Pharmacol. Exp. Ther. 1981; 219: 14–20
- Levy G., Galinsky R. E., Lin J. H. Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion. Drug Metab. Rev. 1982; 13: 1009–1020
- Morris M. E., Levy G. Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid. or sodium sulfate, Clin. Pharmacol. Ther. 1983; 33: 529–536
- Morris M. E., Galinsky R. E., Levy G. Depletion of endogenous inorganic sulfate in the mammalian central nervous system by acetaminophen. J. Pharm. Sci., in press
- Levy G., Matsuzawa T. Pharmacokinetics of salicylamide elimination in man. J. Pharmacol. Exp. Ther. 1967; 156: 285–293
- Cocchetto D. M., Levy G. Absorption of orally administered sodium sulfate in humans. J. Pharm. Sci. 1981; 70: 331–333
- Morris M. E., Levy G. Absorption of sulfate from orally administered magnesium sulfate in man. J. Toxicol.: Clin. Toxicol. 1983; 20: 107–114
- Adriaenssens P. I., Prescott L. F. High performance liquid chromatographic estimation of paracetamol metabolites in plasma. Brit. J. Clin. Pharmacol. 1978; 6: 87–88
- Galinsky R. E., Slattery J. T., Levy G. Effect of sodium sulfate on acetaminophen elimination by rats. J, Pharm. Sci. 1979; 68: 803–805
- Zar J. H. Biostatistical Analysis, 2nd ed. Prentice-Hall, Inc., Englewood Cliffs, N.J. 1984; 190
- Cooney D. O. Activated Charcoal. Antidotal and Other Medical Uses. Marcel Dekker, Inc., New York 1980
- Levy G. Gastrointestinal clearance of drugs with activated charcoal. New Engl. J. Med. 1982; 307: 676–678
- Levy G., Soda D. M., Lampman T. A. Inhibition by ice cream of the antidotal efficacy of activated charcoal. Am, J. Hosp. Pharm. 1975; 32: 289–291
- Sketris I. S., Mowry J. B., Czajka P. A., Anderson W. H., Stafford D. T. Saline catharsis: Effect on aspirin bioavailability in combination with activated charcoal. J. Clin. Pharmacol. 1982; 22: 59–64
- Curtis R. A., Barone J., Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Arch. Intern. Med. 1984; 144: 48–52
- Chin L., Picchioni A. L., Gillespie T. Saline cathartics and saline cathartics plus activated charcoal as antidotal treatments. Clin. Toxicol. 1981; 18: 865–871
- Levy G., Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Clin. Pharmacol. Ther. 1972; 13: 317–322
- Rumack B. H. Acetaminophen overdose. Am. J- Med. 1983; 75: 104–112, Symposium No. 5A
- Lin J. H., Levy G. Effect of experimental renal failure on sulfate retention and acetaminophen pharmacokinetics in rats. J. Pharmacol. Exp. Ther. 1982; 221: 80–84